Artificial Intelligence is fastest growing segment fueling the growth of Gamma Knife Market

 

The global Gamma Knife Market is estimated to be valued at US$ 239.1 Bn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Gamma Knife is used for stereotactic radiosurgery to treat tumors, vascular malformations and other indications in the brain without open surgery. It offers precise targeting of tumors and other lesions while sparing surrounding healthy tissues. The incorporation of artificial intelligence and robotics is increasing the efficiency and accuracy of Gamma Knife treatments.

Market Overview:
Gamma Knife uses multiple beams of gamma rays targeted at tumors and other lesions in the brain from different angles. It allows for high doses of radiation directed at tumors while minimizing exposure of surrounding healthy tissues. The non-invasive nature of Gamma Knife treatment makes it an appealing option for patients.

Market key trends:
One of the key trends in the Gamma Knife market is the increasing adoption of artificial intelligence. AI is being used to improve treatment planning and delivery by automating aspects such as tumor localization, dose calculation and robotics. It analyzes medical images more accurately and comprehensively than humans alone. AI-powered robotics is also enabling finer control over Gamma Knife positioning for superior targeting of tumors. This is improving treatment outcomes while reducing side effects of Gamma Knife procedures.
Here are the segment analysis and key takeaways for the given Gamma Knife market:

Segment Analysis
The global Gamma Knife market is segmented by application into brain metastases, arteriovenous malformations, trigeminal neuralgia, cerebral vascular disorders and others. The brain metastases segment dominated the market in 2022 and is expected to continue its dominance over the forecast period. This is due to the increasing prevalence of brain cancer globally which often spreads from primary cancer sites to the brain via the bloodstream or lymphatic system. Brain metastases are one of the most common complications of cancer and Gamma Knife is an effective non-invasive treatment option for these lesions.

Key Takeaways
The global Gamma Knife market size is expected to witness high growth, exhibiting a CAGR of 5.4% over the forecast period 2023 to 2030, due to the increasing prevalence of cancer and neurological disorders globally. The market size for 2023 is estimated at US$ 239.1 billion.

Regional analysis: North America dominated the global Gamma Knife market in 2022 and is expected to continue its dominance over the forecast period. This can be attributed to continuous technological advancements and higher adoption of Gamma Knife treatment in the region. Asia Pacific region is expected to show the fastest growth rate during the forecast period owing to increasing healthcare expenditure and rising medical tourism in the region.

Key players: Key players operating in the Gamma Knife market are Elekta, American Radiosurgery Inc., Masep Medical Science & Technology Development Co., Ltd., Panacea Medical Technologies Pvt. Ltd., and Nordion (Canada) Inc. These players are focusing on new product launches and strategic collaborations to strengthen their presence in the global market. For instance, in 2022 Elekta launched its Leksell Gamma Knife Icon platform which delivers much higher accuracy and precision for stereotactic radiosurgery treatments.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more